5/9/2025

Janusmed sex and gender

Janusmed sex and gender – etravirine

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Etravirine

Etravirine

Class : A

Show all info

Print

Contact us

  1. Intelence (etravirine). Summary of Product Charateristics. European Medicines Ageny (EMA); 2018.

  2. Girard PM, Campbell TB, Grinsztejn B, Hartikainen J, Rachline A, Nijs S et al. Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest. HIV Med. 2012;13(7):427-35.

  3. Else LJ, Taylor S, Back DJ, Khoo SH. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir Ther. 2011;16(8):1149-67.

  4. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2018-07-24.]

  1. Intelence (etravirine). Summary of Product Charateristics. European Medicines Ageny (EMA); 2018.
  2. Girard PM, Campbell TB, Grinsztejn B, Hartikainen J, Rachline A, Nijs S et al. Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest. HIV Med. 2012;13(7):427-35.
  3. Else LJ, Taylor S, Back DJ, Khoo SH. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir Ther. 2011;16(8):1149-67.
  4. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2018-07-24.]